Trial use of a polymethylmethacrylate membrane for the removal of free immunoglobulin light chains in dialysis patients

NDT Plus

Volumn 3, Issue SUPPL. 1, 2010, Pages

  Oshihara, Wataru ^a   Nagao, Hirotomo ^b   Megano, Hiroshi ^c   Arai, Jiro ^d   Koide, Masahumi ^b   Takada, Mikihiko ^c  

^a Toray Medical Company   (Japan)

^b Medical Satellite Iwakura   (Japan)

^c Medical Satellite Chita   (Japan)

^d Medical & Biological Laboratories Co Ltd   (Japan)

Author keywords

free immunoglobulin light chain; haemodialysis; polymerization; polymethylmethacrylate membrane

Indexed keywords

DIALYSIS FLUID; IMMUNOGLOBULIN LIGHT CHAIN; POLY(METHYL METHACRYLATE); POLYESTER; POLYSULFONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY FAILURE; MALE; POLYMERIZATION; PRIORITY JOURNAL;

EID: 77956018349     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfq029     Document Type: Article

References (10)

1. Cohen G, Rudnicki M, Schmaldienst S, Hörl WH. Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in endstage renal disease patients. Nephrol Dial Transplant 2002; 17: 879-888
2. Hutchison CA, Harding S, Hewins P et al. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1684-1690
3. Hata H, Nishi K, Oshihara Wet al. Adsorption of Bence-Jones protein to polymethylmethacrylate membrane in primary amyloidosis. Amyloid 2009; 16: 108-110
4. Solling K. Free light chains of immunoglobulins. Scand J Clin Lab Invest Suppl 1981; 157: 1-83
5. Wakasugi K, Sasaki M, Suzuki M, Azuma N, Nobuto T. Increased concentrations of free light chain lambda in sera from chronic hemodialysis patients. Biomater Artif Cells Immobilization Biotechnol 1991; 19: 97-109
6. Hutchison CA, Plant T, Drayson M et al. Serum immunoassay is highly sensitive and specific for the diagnosis of monoclonal free light chains in patients with severe renal failure. Nephrol Dial Transplant Plus 2008; 1: ii63a; Suppl 2
7. Wang PX, Sanders PW. Immunoglobulin light chains generate hydrogen peroxide. J Am Soc Nephrol 2007; 18: 1239-1245
8. Li M, Hering-Smith KS, Simon EE, Batuman V. Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol Dial Transplant 2008; 23: 860-870
9. Cohen G, Rudnicki M, Hörl WH. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int Suppl 2001; 78: S48-S52
10. Cohen G. Immunoglobulin light chains in uremia. Kidney Int Suppl 2003; 63: S15-S18